Regulation of Human TLR3 & TLR9 Expression and Function
人类 TLR3 的调控
基本信息
- 批准号:6668819
- 负责人:
- 金额:$ 21.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Cytokines are key regulators of two fundamental and distinct uterine functions: host defense and reproduction. The regulation of separate uterine functions by common cytokines results in cross-communication with significant impact on human health and disease. A shift in cytokine expression can serve the needs of host defense, but alter fetal tolerance contributing to infertility or pregnancy loss. Additionally, estrogen and progesterone can promote pregnancy initiation and maintenance by multiple means including modulation of cytokine expression resulting in altered host defense. To investigate the regulation of uterine cytokine expression, we have focused our attention on the endometrial epithelial cell, a prominent source of uterine cytokine expression and the first uterine cell type to contact an implanting embryo or ascending sperm or microbe. In non-uterine tissues, recognition of microbial molecules (and specific host molecules) by members of the Toll-like receptor (TLR) protein family can stimulate expression of cytokines. However, endometrial TLR expression and function remains unexplored. Preliminary data suggest two overall hypotheses: (1) TLRs stimulate expression of endometrial cytokines and (2) TLR-stimulated cytokine expression is modulated by estradiol and progesterone. In order to test these hypotheses, the proposed studies will focus on the endometrial expression and function of TLR3 and TLR9, which recognize nucleic acid motifs associated with viruses and bacteria, respectively. Initially, the endometrial cell types expressing TLR3 and TLR9 will be determined by immunohistochemical analysis of whole endometrium and real-time quantitative RT-PCR (qRT-PCR) analysis of separated epithelial and stromal cells taken from each phase of the menstrual cycle. The effects of estradiol and progesterone on expression of TLR3 and TLR9 expression in vitro will also be determined in primary endometrial cells as well as epithelial cell-lines (RL95-2 and Ishikawa) by qRT-PCR analysis. TLR3 and TLR9 function in endometrial cells and cell-lines will be assessed by measuring changes in cytokine expression after treatment with TLR3 and TLR9 ligands using ELISA and cytometric bead array (CBA) analyses. Finally, the intracellular signals utilized by endometrial TLRs in stimulating stimulate cytokine expression and their modulation by estradiol and progesterone will be investigated using pathway inhibitors and western blot analysis. Thus, the proposed studies will contribute to an understanding of mechanisms regulating human endometrial cytokine expression, which could lead to the design of pharmacologic therapies for both infectious and reproductive disorders.
描述(由申请人提供):细胞因子是两种基本而独特的子宫功能:宿主防御和生殖的关键调节因子。共同细胞因子对不同子宫功能的调控产生交叉交流,对人类健康和疾病有重要影响。细胞因子表达的改变可以满足宿主防御的需要,但会改变胎儿的耐受性,导致不孕或妊娠丢失。此外,雌激素和孕激素可以通过多种方式促进妊娠的开始和维持,包括调节细胞因子的表达,从而改变宿主的防御。为了研究子宫细胞因子表达的调控,我们将注意力集中在子宫内膜上皮细胞上,它是子宫细胞因子表达的重要来源,也是第一个与着床胚胎或上升精子或微生物接触的子宫细胞类型。在非子宫组织中,toll样受体(TLR)蛋白家族成员对微生物分子(和特定宿主分子)的识别可以刺激细胞因子的表达。然而,子宫内膜TLR的表达和功能尚不清楚。初步数据提出两种假说:(1)tlr刺激子宫内膜细胞因子表达;(2)tlr刺激的细胞因子表达受雌二醇和黄体酮调节。为了验证这些假设,我们将重点研究TLR3和TLR9的子宫内膜表达和功能,它们分别识别与病毒和细菌相关的核酸基序。最初,将通过对整个子宫内膜的免疫组织化学分析和对月经周期各阶段分离的上皮细胞和基质细胞的实时定量RT-PCR (qRT-PCR)分析来确定表达TLR3和TLR9的子宫内膜细胞类型。在体外实验中,我们还将通过qRT-PCR分析雌二醇和孕酮对子宫内膜原代细胞以及上皮细胞系(RL95-2和Ishikawa) TLR3和TLR9表达的影响。TLR3和TLR9在子宫内膜细胞和细胞系中的功能将通过使用ELISA和细胞头阵列(CBA)分析测量TLR3和TLR9配体处理后细胞因子表达的变化来评估。最后,我们将使用途径抑制剂和western blot分析来研究子宫内膜tlr在刺激细胞因子表达以及雌二醇和黄体酮对细胞因子表达的调节中所利用的细胞内信号。因此,所提出的研究将有助于理解调节人类子宫内膜细胞因子表达的机制,这可能导致设计用于感染性和生殖疾病的药物治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN L YOUNG其他文献
STEVEN L YOUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN L YOUNG', 18)}}的其他基金
Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis
合作中心开发改进的子宫内膜异位症诊断和治疗方法
- 批准号:
10474470 - 财政年份:2021
- 资助金额:
$ 21.71万 - 项目类别:
Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis
合作中心开发改进的子宫内膜异位症诊断和治疗方法
- 批准号:
10700014 - 财政年份:2021
- 资助金额:
$ 21.71万 - 项目类别:
Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis
合作中心开发改进的子宫内膜异位症诊断和治疗方法
- 批准号:
10309090 - 财政年份:2021
- 资助金额:
$ 21.71万 - 项目类别:
Diagnosis and Treatment of Endometriosis: A Translational Approach
子宫内膜异位症的诊断和治疗:转化方法
- 批准号:
10700019 - 财政年份:2021
- 资助金额:
$ 21.71万 - 项目类别:
Diagnosis and Treatment of Endometriosis: A Translational Approach
子宫内膜异位症的诊断和治疗:转化方法
- 批准号:
10309092 - 财政年份:2021
- 资助金额:
$ 21.71万 - 项目类别:
Diagnosis and Treatment of Endometriosis: A Translational Approach
子宫内膜异位症的诊断和治疗:转化方法
- 批准号:
10474473 - 财政年份:2021
- 资助金额:
$ 21.71万 - 项目类别:
Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 4/4
使用 GnRH 拮抗剂治疗子宫内膜异位症女性的 IVF 前治疗 - 前瞻性双盲安慰剂对照试验(怀孕) - 应用 4/4
- 批准号:
10025592 - 财政年份:2019
- 资助金额:
$ 21.71万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 21.71万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 21.71万 - 项目类别: